Umer Farooq, Daniel Alcantar, Zahoor Ahmed, Ayokunle T Abegunde
{"title":"血管收缩剂诱发结肠非闭塞性肠系膜缺血的结果:系统回顾","authors":"Umer Farooq, Daniel Alcantar, Zahoor Ahmed, Ayokunle T Abegunde","doi":"10.3121/cmr.2022.1726","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nonocclusive mesenteric ischemia (NOMI) is due to mesenteric arterial hypoperfusion from several causes, such as hypovolemia, heart failure, shock, vasoconstrictors, and severe liver or renal disease. Vasoconstrictor-induced NOMI is usually iatrogenic or associated with cocaine use.</p><p><strong>Objectives: </strong>Anecdotal reports suggest that cocaine-induced NOMI has the highest mortality among vasoconstrictors. This review aims to compare the outcomes of colonic NOMI secondary to cocaine versus other vasoconstrictors.</p><p><strong>Methods: </strong>We conducted a systematic search of MEDLINE from inception through October 2016 to find articles on colonic NOMI. The study's primary outcomes were mortality and hospital length of stay (LOS), while secondary outcomes included the need for surgery. We reported descriptive statistics as percentages or median and interquartile range (IQR). We compared continuous data with the Mann-Whitney test and categorical data with Fisher's exact test; <i>P</i> < 0.05 was statistically significant.</p><p><strong>Results: </strong>Of the 59 studies, 20 case reports and 3 case series (n= 27 patients) met the inclusion criteria. There was no difference in mortality between cocaine-induced NOMI and non-cocaine NOMI (<i>P</i>=1.0). There were statistically significant differences between cocaine and non-cocaine vasoconstrictor-induced colonic NOMI regarding surgery (60% vs. 5.8%, <i>P</i>=0.03) and median LOS (7 days vs. 4 days, <i>P</i>=0.04).</p><p><strong>Conclusion: </strong>Cocaine-induced NOMI and non-cocaine NOMI both appear to have a relatively high but similar mortality rate, but the former is associated with increased requirement for surgery and LOS; prompt recognition of this clinical entity is required to improve outcomes.</p>","PeriodicalId":47429,"journal":{"name":"Clinical Medicine & Research","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2022-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544191/pdf/0200164.pdf","citationCount":"0","resultStr":"{\"title\":\"Outcomes of Vasoconstrictor-Induced Non-Occlusive Mesenteric Ischemia of Colon: A Systematic Review.\",\"authors\":\"Umer Farooq, Daniel Alcantar, Zahoor Ahmed, Ayokunle T Abegunde\",\"doi\":\"10.3121/cmr.2022.1726\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Nonocclusive mesenteric ischemia (NOMI) is due to mesenteric arterial hypoperfusion from several causes, such as hypovolemia, heart failure, shock, vasoconstrictors, and severe liver or renal disease. Vasoconstrictor-induced NOMI is usually iatrogenic or associated with cocaine use.</p><p><strong>Objectives: </strong>Anecdotal reports suggest that cocaine-induced NOMI has the highest mortality among vasoconstrictors. This review aims to compare the outcomes of colonic NOMI secondary to cocaine versus other vasoconstrictors.</p><p><strong>Methods: </strong>We conducted a systematic search of MEDLINE from inception through October 2016 to find articles on colonic NOMI. The study's primary outcomes were mortality and hospital length of stay (LOS), while secondary outcomes included the need for surgery. We reported descriptive statistics as percentages or median and interquartile range (IQR). We compared continuous data with the Mann-Whitney test and categorical data with Fisher's exact test; <i>P</i> < 0.05 was statistically significant.</p><p><strong>Results: </strong>Of the 59 studies, 20 case reports and 3 case series (n= 27 patients) met the inclusion criteria. There was no difference in mortality between cocaine-induced NOMI and non-cocaine NOMI (<i>P</i>=1.0). There were statistically significant differences between cocaine and non-cocaine vasoconstrictor-induced colonic NOMI regarding surgery (60% vs. 5.8%, <i>P</i>=0.03) and median LOS (7 days vs. 4 days, <i>P</i>=0.04).</p><p><strong>Conclusion: </strong>Cocaine-induced NOMI and non-cocaine NOMI both appear to have a relatively high but similar mortality rate, but the former is associated with increased requirement for surgery and LOS; prompt recognition of this clinical entity is required to improve outcomes.</p>\",\"PeriodicalId\":47429,\"journal\":{\"name\":\"Clinical Medicine & Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2022-06-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544191/pdf/0200164.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Medicine & Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3121/cmr.2022.1726\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine & Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3121/cmr.2022.1726","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:非闭塞性肠系膜缺血(NOMI)是由多种原因造成的肠系膜动脉灌注不足引起的,如低血容量、心力衰竭、休克、血管收缩剂以及严重的肝脏或肾脏疾病。血管收缩剂诱发的 NOMI 通常是先天性的,或与使用可卡因有关:轶事报道表明,在血管收缩剂中,可卡因诱发的 NOMI 死亡率最高。本综述旨在比较继发于可卡因和其他血管收缩剂的结肠 NOMI 的结果:我们对 MEDLINE 进行了系统性检索,从开始到 2016 年 10 月,寻找有关结肠 NOMI 的文章。研究的主要结果是死亡率和住院时间(LOS),次要结果包括手术需求。我们以百分比或中位数和四分位数间距 (IQR) 的形式报告了描述性统计数据。我们用 Mann-Whitney 检验比较连续数据,用 Fisher's 精确检验比较分类数据;P < 0.05 为有统计学意义:在 59 项研究中,20 项病例报告和 3 项系列病例(n= 27 名患者)符合纳入标准。可卡因诱发的NOMI与非可卡因诱发的NOMI在死亡率上没有差异(P=1.0)。可卡因和非可卡因血管收缩剂诱发的结肠NOMI在手术(60% vs. 5.8%,P=0.03)和中位LOS(7天 vs. 4天,P=0.04)方面存在统计学差异:结论:可卡因诱导的结肠NOMI和非可卡因诱导的结肠NOMI的死亡率相对较高,但两者相似,但前者与手术需求和住院时间增加有关;需要及时识别这一临床实体以改善预后。
Outcomes of Vasoconstrictor-Induced Non-Occlusive Mesenteric Ischemia of Colon: A Systematic Review.
Background: Nonocclusive mesenteric ischemia (NOMI) is due to mesenteric arterial hypoperfusion from several causes, such as hypovolemia, heart failure, shock, vasoconstrictors, and severe liver or renal disease. Vasoconstrictor-induced NOMI is usually iatrogenic or associated with cocaine use.
Objectives: Anecdotal reports suggest that cocaine-induced NOMI has the highest mortality among vasoconstrictors. This review aims to compare the outcomes of colonic NOMI secondary to cocaine versus other vasoconstrictors.
Methods: We conducted a systematic search of MEDLINE from inception through October 2016 to find articles on colonic NOMI. The study's primary outcomes were mortality and hospital length of stay (LOS), while secondary outcomes included the need for surgery. We reported descriptive statistics as percentages or median and interquartile range (IQR). We compared continuous data with the Mann-Whitney test and categorical data with Fisher's exact test; P < 0.05 was statistically significant.
Results: Of the 59 studies, 20 case reports and 3 case series (n= 27 patients) met the inclusion criteria. There was no difference in mortality between cocaine-induced NOMI and non-cocaine NOMI (P=1.0). There were statistically significant differences between cocaine and non-cocaine vasoconstrictor-induced colonic NOMI regarding surgery (60% vs. 5.8%, P=0.03) and median LOS (7 days vs. 4 days, P=0.04).
Conclusion: Cocaine-induced NOMI and non-cocaine NOMI both appear to have a relatively high but similar mortality rate, but the former is associated with increased requirement for surgery and LOS; prompt recognition of this clinical entity is required to improve outcomes.
期刊介绍:
Clinical Medicine & Research is a peer reviewed publication of original scientific medical research that is relevant to a broad audience of medical researchers and healthcare professionals. Articles are published quarterly in the following topics: -Medicine -Clinical Research -Evidence-based Medicine -Preventive Medicine -Translational Medicine -Rural Health -Case Reports -Epidemiology -Basic science -History of Medicine -The Art of Medicine -Non-Clinical Aspects of Medicine & Science